The second of a three-year conference series on Personalised Medicine, Ethics and the Market, this multidisciplinary two-day conference will focus on Intellectual Property (IP) issues. In particular, the programme will bring together academics, practitioners and industry experts to debate ways to promote biomedical innovation in the public interest. Although current debate tends to be polarized, a spectrum of opportunities exists between strong proprietary approaches and unrestricted openness, and the conference will discuss ways to address the challenges and opportunities for personalised medicine. Topics to be discussed include innovation in diagnostics, data sharing and access to clinical trial data, open innovation and the impact of patents on clinical practice.
Talks from Professor Graham Dutfield (University of Leeds), Professor Shobita Parthasarathy (University of Michigan), Dr Nick Scott-Ram (Oxford Academic Health Science Network), Dr Mark Bale (Genomics England), Dr Lawrence Cullen (UK IPO), Chris Moran (Wellcome Trust), Dr Siva Thambisetty (London School of Economics), Dr Katerina Sideri (University of Crete, Technis research group), Dr Aisling McMahon (Newcastle University), Dr Naomi Hawkins (University of Exeter), Dr Richard Reschen (Oxford University Innovation), Dr Johnathon Liddicoat (University of Cambridge), Liam Curren (Genomics PLC), Professor Timo Minssen (University of Copenhagen), Professor Isabelle Huys (KU Leuven), Professor Chas Bountra (Structural Genomic Consortium, University of Oxford).
A programme for the day can be found here.